Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-04-004878
Filing Date
2004-09-13
Accepted
2004-09-13 16:47:19
Documents
11
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d60697_10-k.txt 10-K 439632
3 OUTSIDE DIRECTORS' COMPENSATION ARRANGEMENT d60697_ex10-22.txt EX-10.22 2678
4 EMPLOYMENT AGREEMENT d60697_ex10-30.txt EX-10.30 89263
5 EXECUTIVE DEFERRED COMPENSATION PLAN d60697_ex10-31.txt EX-10.31 31682
6 STATEMENT RE: COMPUTATION OF RATIOS d60697_ex12-1.txt EX-12.1 2274
7 SUBSIDIARIES OF THE REGISTRANT d60697_ex-21.txt EX-21 663
8 CONSENTS OF EXPERTS AND COUNSEL d60697_ex-23.txt EX-23 1061
9 CERTIFICATIONS REQUIRED UNDER SECTION 302 d60697_ex31-1.txt EX-31.1 4425
10 CERTIFICATIONS REQUIRED UNDER SECTION 302 d60697_ex31-2.txt EX-31.2 4295
11 CERTIFICATIONS REQUIRED UNDER SECTION 906 d60697_ex32-1.txt EX-32.1 1789
12 CERTIFICATIONS REQUIRED UNDER SECTION 906 d60697_ex32-2.txt EX-32.2 1868
  Complete submission text file 0001169232-04-004878.txt   582792
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 041027917
SIC: 2836 Biological Products, (No Diagnostic Substances)